Vancouver, British Columbia--(Newsfile Corp. - October 23, 2024) - Elemental Altus Royalties Corp. (TSXV: ELE) (OTCQX: ELEMF) ("Elemental Altus" or the "Company") notes that following the announcement ...
12.3M warrants with a $0.10 exercise price expired unexercised, minimizing potential dilution $270K in cash proceeds from 2.7M warrant exercises at $0.10, demonstrating shareholder support of the ...
Moleculin Biotech's stock crashes as a capital raise triggers fears of severe dilution, overshadowing positive Phase 3 AML trial results for Annamycin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results